Xeris Biopharma Holdings (XERS) Short term Debt (2023 - 2026)
Xeris Biopharma Holdings' (XERS) quarterly Short term Debt came in at $12.0 million in Q1 2025, up 1071.3% YoY from $1.0 million in Q1 2024, and down 20.81% on a QoQ basis from $15.1 million in Q4 2024.
Xeris Biopharma Holdings (XERS) Short term Debt (2023 - 2026) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 3 years of Short term Debt data on file, last reported at $12.0 million in Q1 2025.
- Quarterly Short term Debt rose 1071.3% year-over-year to $12.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $12.0 million (up 1071.3% YoY) and the FY2024 annual result came in at $15.1 million, changed N/A from the prior year.
- Short term Debt declined to $12.0 million in Q1 2025, from $15.1 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $17.5 million in Q3 2023 to a low of $420000.0 in Q2 2024.
- A 3-year average of $11.6 million and a median of $15.0 million in 2023 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2024 — Short term Debt plunged 97.48% — and 2025, when it jumped 1071.3%.
- Tracing XERS's Short term Debt over 3 years: stood at $17.5 million in 2023, then decreased by 13.79% to $15.1 million in 2024, then slipped by 20.81% to $12.0 million in 2025.
- The last three Short term Debt figures came in at $12.0 million (Q1 2025), $15.1 million (Q4 2024), and $15.1 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Xeris Biopharma Holdings | 1.51 Bn | 1.39 Bn | 79.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.78 Mn |
| Mar 31, 2025 | 11.96 Mn |
| Dec 31, 2024 | 15.10 Mn |
| Sep 30, 2024 | 15.06 Mn |
| Jun 30, 2024 | 420,000.00 |
| Mar 31, 2024 | 1.02 Mn |
| Sep 30, 2023 | 17.52 Mn |
| Jun 30, 2023 | 16.64 Mn |
| Mar 31, 2023 | 14.96 Mn |